MU, M., AM, H., SG, C., LC, M., KB, C., S, A., . . . GS, G. M. (2021). Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma, 62(1), 158. https://doi.org/10.1080/10428194.2020.1821009
Chicago Style (17th ed.) CitationMU, Mushtaq, et al. "Comparison of Salvage Chemotherapy Regimens and Prognostic Significance of Minimal Residual Disease in Relapsed/refractory Acute Myeloid Leukemia." Leukemia & Lymphoma 62, no. 1 (2021): 158. https://doi.org/10.1080/10428194.2020.1821009.
MLA (9th ed.) CitationMU, Mushtaq, et al. "Comparison of Salvage Chemotherapy Regimens and Prognostic Significance of Minimal Residual Disease in Relapsed/refractory Acute Myeloid Leukemia." Leukemia & Lymphoma, vol. 62, no. 1, 2021, p. 158, https://doi.org/10.1080/10428194.2020.1821009.